Feasibility and Comparison of Continuously Monitored Vital Signs in Pediatric Patients With Cancer.

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

September 16, 2021

Primary Completion Date

March 1, 2022

Study Completion Date

March 1, 2022

Conditions
Pediatric CancerFebrile NeutropeniaOncologyChemotherapy-induced Neutropenia
Interventions
DEVICE

Everion®

The Everion® is an on-skin wearable devices measuring vital signs. It will be given to the participants for the duration of 2 weeks (fourteen days) with the instruction to wear all the time, with exception of the time needed for the patients' hygiene.

DEVICE

CORE®

The CORE® is an on-skin wearable devices measuring vital signs. It will be given to the participants for the duration of 2 weeks (fourteen days) with the instruction to wear all the time, with exception of the time needed for the patients' hygiene.

Trial Locations (2)

3010

Inselspital, Bern

Unknown

University Children's Hospital Basel, University of Basel, Basel

All Listed Sponsors
lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT04914702 - Feasibility and Comparison of Continuously Monitored Vital Signs in Pediatric Patients With Cancer. | Biotech Hunter | Biotech Hunter